May 25, 2021 C-Path Virtual Workshop to Feature Latest Advances in Clinical Trials for T1D More than 300 Attendees and 20 Speakers Are Expected to Participate in the International Workshop, June 15-16 TUCSON, Ariz., May 2
May 20, 2021 The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation
May 19, 2021-May 20, 2021 View Now | 2021 PKD Regulatory Summit | May 19-20 The Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium (PKDOC), The PKD Foundation and Otsuka invite you vi
May 19, 2021 View Now | Interpretation of novel biomarkers in related diseases through data interoperability in a pan-rare disease database When: May 19, 2021, 12 p.m. ET Example Disease: Polycystic kidney disease and kidney transplant Presenters: Jagde
May 19, 2021 ERA4TB Update NEWSLETTER: The ERA4TB (European Regimen Accelerator for Tuberculosis) project, a public-private initiative devoted
May 18, 2021 C-Path Request for Proposal for External Communications Critical Path Institute (C-Path) is seeking a proposal, including timelines and budget, for external marketing, communications, pu
May 12, 2021 C-Path Announces Accelerated Data Sharing Collaboration with Tufts Medical Center FDA Grant Supports Use of Real-World Data to Generate Real-World Evidence in Neonates TUCSON, Ariz., May 12, 2021 — Criti
May 7, 2021 Pediatric COVID-19 Mitigation Strategies Virtual Workshop Click here for WebEx link On May 7th, 2021, 12:00-1:30 PM Eastern Time (US), the PRO Consortium and Rare Disease Su
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop Friday May 7, 2021 12:00 – 1:30 pm Ea
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w